Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0B0BJ
|
|||
Drug Name |
Pyridoindole derivative 1
|
|||
Synonyms |
PMID25656651-Compound-22a
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA UNIVERSITE DE GENEVE UNIVERSITE CLAUDE BERNARD LYON 1
|
|||
Structure |
Download2D MOL |
|||
Formula |
C28H24N4O
|
|||
Canonical SMILES |
C1COCCN1C2=CN=C(C=C2)C3=CC4=C(C=C3)NC5=C4C=C(C=N5)C=CC6=CC=CC=C6
|
|||
InChI |
1S/C28H24N4O/c1-2-4-20(5-3-1)6-7-21-16-25-24-17-22(8-10-27(24)31-28(25)30-18-21)26-11-9-23(19-29-26)32-12-14-33-15-13-32/h1-11,16-19H,12-15H2,(H,30,31)/b7-6+
|
|||
InChIKey |
RPPRUVFNILNTHG-VOTSOKGWSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Fusion protein Bcr-Abl (Bcr-Abl) | Target Info | Inhibitor | [1] |
Target's Patent Info | Fusion protein Bcr-Abl (Bcr-Abl) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.